MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 21 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $20,739,000 | -4.8% | 13,780,000 | -6.8% | 2.83% | -45.7% |
| Q4 2015 | $21,781,000 | -4.1% | 14,780,000 | +1.9% | 5.21% | +120.2% |
| Q3 2015 | $22,711,000 | -35.3% | 14,500,000 | -13.3% | 2.37% | -50.6% |
| Q2 2015 | $35,081,000 | +14.8% | 16,729,000 | +9.8% | 4.79% | -24.4% |
| Q1 2015 | $30,553,000 | +979.2% | 15,229,000 | +915.3% | 6.34% | +1631.1% |
| Q4 2014 | $2,831,000 | -48.1% | 1,500,000 | -57.1% | 0.37% | -42.7% |
| Q3 2014 | $5,455,000 | +15.2% | 3,500,000 | 0.0% | 0.64% | +30.7% |
| Q2 2014 | $4,734,000 | +15.6% | 3,500,000 | -12.5% | 0.49% | +69.8% |
| Q1 2014 | $4,095,000 | -2.5% | 4,000,000 | 0.0% | 0.29% | -19.1% |
| Q4 2013 | $4,200,000 | +53.8% | 4,000,000 | +33.3% | 0.36% | +53.4% |
| Q3 2013 | $2,730,000 | – | 3,000,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,762,000 | $22,928,000 | 0.34% |
| WOLVERINE ASSET MANAGEMENT LLC | 9,998,000 | $8,555,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,331,000 | $1,138,000 | 0.04% |
| PUTNAM INVESTMENTS LLC | 2,876,000 | $2,459,000 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 3,300,000 | $2,838,000 | 0.01% |
| AMERIPRISE FINANCIAL INC | 3,320,000 | $2,839,000 | 0.00% |
| UBS Group AG | 1,000 | $1,000 | 0.00% |
| Jefferies Group LLC | 10,000 | $8,000 | 0.00% |
| JPMORGAN CHASE & CO | 2,015,000 | $1,730,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 7,000 | $7,000 | 0.00% |